Latest News, reports & updates

New report calls for organisations involved with hepatitis C testing, treatment and care to improve data sharing

The new report, ‘Joining the Dots: Linking pathways to hepatitis C diagnosis and treatment’, highlights that, with people being diagnosed with hepatitis C at various different locations such as at a drugs service, prison, GP practice, or outreach service, it is crucial these organisations have systems that can process and share patient information efficiently. Effective...

read more >>

£4 million pledged to testing for hepatitis C in community pharmacies

The announcement came this week with the publication of The Community Pharmacy Contractual Framework for 2019/20 to 2023/24 by the Department of Health and Social Care, NHS England, NHS Improvement, and the Pharmaceutical Services Negotiating Committee. The Framework sets out that over 2019/20 and 2020/21, £2 million will be invested each year to support hepatitis...

read more >>

LJWG pilot celebrated as best practice by EMCDDA

The EMCDDA is an EU agency existing to provide the EU’s Member States with a factual overview of European drug problems and a solid evidence base to support the drugs debate. In advance of World Hepatitis Day, the organisation published ‘Hepatitis C: new models of care for drugs services’. This report aims to highlight the...

read more >>

Mayor joins charities and doctors to spread the World Hepatitis Day ‘Get tested for hepatitis C’ message

Hepatitis C is a blood-borne virus, which primarily affects the liver. People can live with hepatitis C for decades without symptoms but untreated cases can cause fatal cirrhosis and liver cancer. Public Health England estimate there are 14,200 people living with hepatitis C in London and 113,000 people with the virus in England, around half...

read more >>

A call to action: Overcoming barriers to allow treatment in community pharmacies (July 2019)

Fully embracing the strategic priorities and ambitions to eliminate hepatitis C as a public health threat by 2025, the London Joint Working Group have been exploring the options around the introduction of a community pharmacy hepatitis C treatment service. Despite full local system support for the initiative and examples of similar services being introduced successfully...

read more >>

Minister urged to let pharmacies dispense hepatitis C treatments

Following the success of the LJWG’s hepatitis C pharmacy testing pilot, the group has joined forces with the All-Party Parliamentary Group on Liver Health to urge the government to allow pharmacies to dispense hepatitis C treatments. Chemist + Druggist magazine has reported on the issue, highlighting the LJWG pilot’s findings that 84% of people who...

read more >>

LJWG shortlisted for C+D awards for innovative hepatitis C pharmacy testing pilot

Working closely with 8 pharmacies across London, our hepatitis C pharmacy testing project offered point-of-care tests to people who use needle exchange services, engaging with and meeting the unmet needs of this vulnerable and high-risk group. The project developed a working model of testing and referral into treatment that is now being rolled out in...

read more >>

London Assembly passes motion calling on Mayor to raise awareness of hepatitis C

The motion stated:  “This Assembly believes that hepatitis C is a serious public health and health inequalities issue in London and urges the London Mayor, in his role as Chair of the London Health Board, to lead efforts to raise awareness about the condition and new curative treatments available. This Assembly also calls on the...

read more >>

7 years to go: Healthcare leaders call for united approach to eliminate hepatitis C by 2025

More must be done to coordinate drugs services, prisons, pharmacies, GP practices and secondary care around one strategic vision if London is to become the first global city to eliminate hepatitis C, the annual conference of the London Joint Working Group on Substance Use and Hepatitis C (LJWG) heard this week. The conference brought together...

read more >>

LJWG awarded ‘Highly Commended’ for showing Excellence in Collaboration and Partnerships for our pharmacy testing pilot

On 22 November 2018 the LJWG was awarded ‘Highly Commended’ for ‘Excellence in Collaboration and Partnerships’ at the prestigious PMEA awards for phase 1 of our HCV pharmacy testing pilot. The awards night was hosted by TV presenter Natasha Kaplinsky.  The judges commented saying: “The work by LJWG on Substance Use and Hepatitis C, MSD...

read more >>